EASTMAN CHEMICAL CO
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.51B | $2.18B | — | $2.20B | $2.29B | $2.29B | — | $2.46B |
| Cost of Revenue | $1.95B | $1.75B | — | $1.77B | $1.78B | $1.72B | — | $1.86B |
| Gross Profit | $560.0M | $431.0M | — | $433.0M | $506.0M | $567.0M | — | $605.0M |
| Gross Margin | 22.3% | 19.8% | — | 19.7% | 22.1% | 24.8% | — | 24.6% |
| Operating Expenses | ||||||||
| Research & Development | $65.0M | $60.0M | — | $63.0M | $67.0M | $67.0M | — | $65.0M |
| SG&A Expense | $185.0M | $178.0M | — | $160.0M | $157.0M | $182.0M | — | $183.0M |
| Operating Income | $256.0M | $136.0M | — | $134.0M | $169.0M | $253.0M | — | $280.0M |
| Operating Margin | 10.2% | 6.2% | — | 6.1% | 7.4% | 11.0% | — | 11.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $256.0M | $136.0M | — | $134.0M | $169.0M | $253.0M | — | $280.0M |
| Income Tax Expense | $72.0M | $29.0M | — | $87.0M | $29.0M | $70.0M | — | $99.0M |
| Net Income | $183.0M | $107.0M | — | $47.0M | $140.0M | $182.0M | — | $180.0M |
| Net Margin | 7.3% | 4.9% | — | 2.1% | 6.1% | 7.9% | — | 7.3% |
| EPS (Basic) | $1.60 | $0.93 | — | $0.41 | $1.22 | $1.58 | — | $1.55 |
| EPS (Diluted) | $1.59 | $0.93 | — | $0.40 | $1.20 | $1.57 | — | $1.53 |
| Shares Outstanding (Basic) | 114.3M | 114.2M | 223.9M | 114.4M | 115.0M | 115.2M | 223.6M | 116.4M |
| Shares Outstanding (Diluted) | 115.3M | 115.0M | 223.9M | 115.4M | 116.2M | 116.5M | 223.6M | 117.8M |
| Dividends Per Share | $0.84 | $0.84 | — | $0.83 | $0.83 | $0.83 | — | $0.81 |